Related Experiment Videos
Multimodality management of regionally advanced non-small-cell lung cancer
1Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.
Seminars in Oncology
|August 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN).
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC).
Cancer treatment reviews·2011
Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.
Seminars in oncology·2026